DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sulkowski M, Lok AS, Willner IR. , et al.
High efficacy of glecaprevir/pibrentasvir in patients with chronic HCV GT1 infection who failed prior treatment with NS5A inhibitor plus sofosbuvir regimens.
Hepatology 2018;
68 (Suppl.): 141A
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.